Insider Transactions in Q4 2024 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
Jason S Carter Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,000
+50.0%
|
-
|
|
Nov 13
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
30,625
-3.65%
|
$1,500,625
$49.84 P/Share
|
|
Nov 13
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,625
+3.4%
|
$61,250
$2.9 P/Share
|
|
Oct 28
2024
|
Beth C Seidenberg |
SELL
Open market or private sale
|
Direct |
15,000
-5.13%
|
$720,000
$48.78 P/Share
|
|
Oct 23
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
19,375
-1.53%
|
$794,375
$41.03 P/Share
|
|
Oct 23
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,375
+1.48%
|
$38,750
$2.9 P/Share
|
|
Oct 09
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
15,625
-2.45%
|
$593,750
$38.46 P/Share
|
|
Oct 09
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+2.38%
|
$31,250
$2.9 P/Share
|